Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New drug for improving ED filed for approval in U.S., Mexico

Sep. 26, 2001

NCX-2111: a new NicOx NO-releasing compound for micturition disorders

Sep. 26, 2001

Phase II trial data support efficacy of duloxetine in stress urinary incontinence

Sep. 21, 2001

Muscarinic receptor binding profile of YM-905 correlated with pharmacological activity

Sep. 20, 2001

Tiagabine as a potential treatment option for overactive bladder

Sep. 20, 2001

Human testing of injectable urethral bulking agent in progress

Sep. 20, 2001

Men with diabetes-related ED respond well to on-demand treatment with IC-351

Sep. 17, 2001

Interneuron initiates U.S. phase III clinical trial with trospium for overactive bladder

Sep. 13, 2001

Topiglan development continues to move forward

Sep. 12, 2001

BTG obtains rights to ANF peptide technology from Genentech

Sep. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...